SEBI Clears MakeMyTrip's India IPO

MakeMyTrip (India) Ltd received SEBI approval for its IPO, which will be an OFS by its Nasdaq-listed parent and subsidiary. The IPO could raise over $1B. MakeMyTrip India will remain a subsidiary post-listing. The company reported a Q2 FY27 profit of $1.8M and revenue of $235.2M.

Original reporting
Published Nov 10, 2026, 6:07 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 8:41 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SEBI Clears MakeMyTrip's India IPO — source image
Decision brief

The 30-second read

$MMYTNeutralMed
01

Why it matters

The approval enables a sizable capital raise (~$1B) and may improve the parent’s balance sheet and visibility in the Indian market.

02

Market read

First‑report regulatory clearance for a major Indian IPO by a US‑listed tech firm, creating a near‑term trading catalyst.

03

What to watch

Potential regulatory or tax complications for foreign investors in the Indian offering could dampen demand.

Relevance 8/10Novelty 8/10Timing: post‑approval, upcoming IPO

Background

MakeMyTrip, a Nasdaq‑listed online travel aggregator, received final SEBI observations permitting its India subsidiary to launch an OFS‑only IPO.

Company-level read

Ticker impact

$MMYTNeutralHigh confidence
Context

SEBI approved MakeMyTrip's India IPO, allowing the parent to proceed with an OFS offering.

Expected impact

potential upward pressure as investors price in the upcoming IPO proceeds.

Evidence & confidence

Regulatory clearance is a concrete catalyst; the IPO size (~$1B) is material for a mid‑cap listed company.

Market effects

Highlights continued IPO activity in India's tech travel sector, may spur interest in similar companies.

Adds to positive sentiment for Indian equity markets and foreign‑listed firms seeking Indian listings.

Shows cross‑border capital raising trends; may attract global investors to Indian travel tech.

Counterpoint

If the Indian market remains volatile, the OFS could be priced down, limiting upside for MMYT.

Key entities

  • MakeMyTrip (parent)

    Nasdaq‑listed OTA seeking to raise funds via its India subsidiary.

  • SEBI

    Indian securities regulator that granted the IPO approval.

Related articles

HighAI 8/10

MakeMyTrip India Subsidiary Gets Sebi Nod for IPO

MakeMyTrip's India subsidiary, MMT India, received Sebi's approval for its IPO. The offering includes an OFS by MakeMyTrip and its subsidiary, ibibo Group Holdings. The IPO aims to enhance brand visibility and strengthen financial position, with proceeds used for growth and acquisitions.

$MMYTMed

MakeMyTrip acquires Quick Ride's ride-pooling business

MakeMyTrip acquired a majority stake in Quick Ride's ride-pooling business, expanding into daily urban commuting. The Nasdaq-listed company will integrate Quick Ride into its ground transportation division, which includes redBus and Savaari. Quick Ride's promoters will continue managing the ride-pooling business, while its EV taxi operations remain separate. The acquisition aims to serve frequent, short-distance commuters, leveraging MakeMyTrip's existing travel experience.

$MMYTMed

MakeMyTrip India IPO Gets SEBI Approval for Listing

MakeMyTrip (India) Ltd received SEBI's approval for its IPO on November 6, 2026. The Nasdaq-listed parent company's subsidiary filed draft documents in July. The IPO will involve an offer for sale by MakeMyTrip and ibibo Group Holdings, with proceeds going to selling shareholders. MMT India will remain a subsidiary post-listing. IPO size, price band, and launch date are yet to be announced.

$MMYTMed

MakeMyTrip’s India arm gets Sebi nod to float IPO

MakeMyTrip's Indian subsidiary, MMT India, received Sebi approval for an IPO. The offering, expected to be a sale of equity shares by the parent and ibibo Group, aims to boost visibility, attract talent, and strengthen the parent's cash position. MMT India will remain a subsidiary post-IPO. Details on offer size, price, and timetable are yet to be disclosed.

MedAI 8/10

Sebi Clears MakeMyTrip India Arm's Proposed IPO

MakeMyTrip's India subsidiary, MMT India, received Sebi approval for its IPO. The offer includes equity shares from MakeMyTrip and its subsidiary, ibibo Group. Proceeds will go to the parent companies. MMT India will remain a subsidiary post-IPO, with its financials consolidated in the parent's results.